Unibest
← Back to patent-cliff list

CAS 187223-15-0

(2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(((2-((tert-butoxycarbonyl)amino)ethyl)carbamoyl)oxy)pyrrolidine-2-carboxylic acid

Codes: PASI-006

Application context (from source-drug indications)

Cushing's syndromePasireotide DiaspartatePituitary ACTH hypersecretionPasireotide DiaspartatePost-bariatric hypoglycaemiaPasireotide DiaspartateCarcinoid tumourPasireotide DiaspartateNeuroendocrine tumourPasireotide DiaspartateCluster headachePasireotide Diaspartate

Source drugs (routes using this intermediate)

DrugTierExpiry
Pasireotide DiaspartateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Pasireotide DiaspartateOptimised routesteps: 10total yield: 5.133 g
(2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(((2-((tert-butoxycarbonyl)amino)ethyl)carbamoyl)oxy)pyrrolidine-2-carboxylic acid→1-((9H-fluoren-9-yl)methyl) 2-methyl (2S,4R)-4-(((2-((tert-butoxycarbonyl)amino)ethyl)carbamoyl)oxy)pyrrolidine-1,2-dicarboxylate→PASI-017→PASI-018→PASI-019→PASI-020→PASI-021→PASI-022→#N/A

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.